Literature DB >> 7212105

Methodologic standards for treatment outcome research in schizophrenia.

W T Carpenter, D W Heinrichs, T E Hanlon.   

Abstract

Considerable progress has been made in increasing the formal correctness of outcome research in schizophrenia by employing strict methodologic standards. However, based on a recent review of the literature, the authors note that insufficient attention has been directed toward the meaningfulness of such research. The interest of a particular study derives from its application beyond the specific patients treated; lack of attention to meaningfulness encourages the researcher to posit unjustified or overly generalized conclusions, resulting in the widespread adoption of questionable treatment strategies or the dismissal of potentially useful ones. Increased attention to meaningfulness will make the conclusions of this type of research more valuable, both from pragmatic and theoretical standpoints.

Entities:  

Mesh:

Year:  1981        PMID: 7212105     DOI: 10.1176/ajp.138.4.465

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  3 in total

1.  Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

Authors:  D A Revicki; L A Genduso; S H Hamilton; D Ganoczy; C M Beasley
Journal:  Qual Life Res       Date:  1999-08       Impact factor: 4.147

2.  Prognosis of the course of schizophrenic psychoses compared to other psychiatric illnesses. Catamnestic treatment and outcome 1 year after discharge.

Authors:  W Gaebel; A Pietzcker
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

Review 3.  Patients' subjective experiences of antipsychotics: clinical relevance.

Authors:  Jonathan S E Hellewell
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.